A Clinical Comparative study of Shilajatu Vataka and Gokshuradi Guggulu in the Management of Diabetic Polyneuropathy - SVGGDP

IPGT AND RA GA0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1)Patients of either sex, age group, above 40yrs and below 70yrs.
•2)Metabolically stable Type 2 Diabetic with symptomatic diabetic sensorimotor polyneuropathy (DSPN) who are with or without medications (modern medications like Metformin, Thiazolidinediones, Alpha glucosidase inhibitors, Sulphonilureas, Meglitinides, Incretin etc.)
•3)Both freshly detected as well as previously treated cases will be included for the study.
•4)Presence of classical signs and symptoms Madhumeha.
•5)Patients with Diabetic Neuropathy having N1a, N2a and N2b grading will be included for the study.

•1)Patient age below 40 years and above 70 years.
•2)Patients with other metabolic & endocrine disorders.
•3) Patients suffering from HIV, TB etc, infectious diseases.
•4)Patients having any other malignancies, any other serious illnesses.
•5)Patients with uncontrolled diabetes.
•6) Patients with diabetic wounds / ulcers.
•7)Patients with complications like Diabetic nephropathy, Diabetic keto acidosis & Diabetic coma.
•8)Patients with Diabetic Neuropathy N0 and N3 will be excluded from the study.

发起方

IPGT AND RA GA